Spiroperidol binding sites on mouse lymphoid cells. Effects of ascorbic acid and psychotropic drugs.
Since highly differentiated cells of mammalian immune systems reportedly have binding sites for a variety of neurohumoral agents, we investigated parameters related to possible existence of dopamine receptors on murine lymphoid cells. Using a dopamine antagonist, [3H]spiroperidol, we found evidence for displaceable binding on mouse spleen cells. Total and displaceable (10 microM haloperidol) binding of spiroperidol was markedly enhanced by the absence of ascorbic acid in the incubation medium. Displaceable binding of a dopamine receptor agonist [( 3H]ADTN) could not be found on lymphoid cells either in the presence or absence of ascorbic acid. In the absence of ascorbate, displaceable spiroperidol binding to mouse spleen cells revealed partially saturable, but complex, kinetics and we calculated positive cooperativity at low ligand concentrations.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D001205:Ascorbic Acid / Q000494:pharmacology*; D002069:Butaclamol / Q000494:pharmacology; D005260:Female; D007111:Immunity, Cellular / Q000187:drug effects; D007700:Kinetics; D008214:Lymphocytes / Q000166:cytology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D011954:Receptors, Dopamine / Q000032:analysis* / Q000187:drug effects; D013154:Spleen / Q000166:cytology; D013237:Stereoisomerism
D011954:Receptors, Dopamine; C031611:spiroperidol receptor; D002069:Butaclamol; D001205:Ascorbic Acid